| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Novartis is currently facing significant challenges in its product and service development, primarily due to a series of high-profile drug trial failures, particularly concerning cardiovascular and cholesterol medications. These failures have raised concerns about the effectiveness of their products and have adversely impacted investor confidence and stock performance. Moreover, ongoing challenges in the clinical pipeline are creating doubts about the future success of their drug development initiatives. The company must navigate these setbacks to reposition itself effectively in the market. |
| The price action of Novartis AG (NVS) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -3.4 is extremely bearish. The market sentiment at -2.2 is extremely bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. NVS is likely to move down since both trend sentiment and market sentiment are negative. The positive sentiment force for sector is at 0.3, and the negative at -2.5 on 2026-09-11. The forces of Sentiment towards Fundamentals (-7.4), Stock Price Trend (-3.4), Valuation Sentiment (-3.2), Sector Price Trend (-1.1), and Market Risk Appetite (-0.4) will drive down the price. The forces of Price Level Sentiment (0.5), and Option Sentiment (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| NVS | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | 0%(0.1%) | 137.19 | 6.26% | 3 | 27 | 36 | -0.22% | -1.12% | -3.4 | -0.1 | 0.4% | -2.2 | Short | 70% | -7.4 | -8 |
| 2026-09-10 | 0%(0.1%) | 137.49 | 5.65% | -3 | 31 | 38 | -0.01% | -1.3% | -3.5 | -0.1 | 0.3% | -1.7 | Short | 70% | -6.9 | -7.5 |
| 2026-09-09 | 0%(0.1%) | 137.5 | 4.95% | -13 | 29 | 34 | -0.17% | -1.47% | -3.6 | -0.8 | 6.4% | -1.5 | Short | 70% | -5.7 | -6 |
| 2026-09-08 | 1%(0.1%) | 137.74 | 4.03% | -30 | 36 | 1 | -13.91% | -1.26% | -2.8 | -2.5 | 7.7% | -1.1 | Wait | 50% | -4.6 | -7.6 |
| 2026-09-07 | 0%(0%) | 0.6 | -2.5 | -0.3 | -2.5 | -1 | ||||||||||
| 2026-09-06 | 0%(0%) | 0.6 | -2.5 | -0.2 | -1.8 | -1 | ||||||||||
| 2026-09-05 | 0%(0%) | 0.6 | -2.5 | -0.1 | -1.1 | -4 | ||||||||||
| 2026-09-04 | 0%(0%) | 160 | 2.34% | 73 | 60 | 34 | -1.88% | 0.06% | 0.6 | 0 | 0.7% | 0.1 | Long | 55% | -1.2 | -1 |
| 2026-09-03 | 0%(0%) | 163.07 | 2.24% | 96 | 66 | 70 | 0.39% | 0.44% | 1.3 | 0.2 | 0.4% | 0.1 | Wait | 50% | -2.2 | -1 |
| 2026-09-02 | 0%(0%) | 162.44 | 2.05% | 99 | 64 | 62 | 0.74% | 0.13% | 0.7 | 0.5 | 2.4% | -0.7 | Wait | 50% | -3.9 | -1 |
| Short is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very weak. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Novartis AG (NVS) Equity Research Report Wed. Mar 11, 2026 | ||
| 2026-09-11 22:46:27 The mention of 'bad diagnoses' implies potential legal and regulatory pressures impacting the company. |
| 2026-09-11 22:46:27 The article indicates ongoing challenges faced by Novartis, suggesting a negative outlook on their earnings and market position. |
| 2026-09-11 17:07:58 There are growing concerns regarding Novartis's drug pipeline stability due to recent failures, prompting discussions about future product development. |
| 2026-09-11 17:07:58 Clinical trial setbacks have negatively impacted Novartis's stock valuation, leading to increased volatility in its share price. |
| 2026-09-11 17:07:58 Investor sentiment is turning cautious as they demand accountability regarding the company's recent M&A activities in light of underperforming drug trials. |
| 2026-09-11 17:07:58 The company's aggressive $30 billion spending on acquisitions raises concerns about the efficacy and success of these investments following recent trial failures. |
| 2026-09-11 17:07:58 Investors are scrutinizing Novartis's approach to mergers and acquisitions, particularly in light of recent clinical setbacks that have affected its stock performance. |
| 2026-09-11 11:46:54 Negative outcome of trials impacting investor confidence and stock value. |
| 2026-09-11 11:46:54 Stock declines linked to trial setbacks and acquisition strategy concerns. |
| 2026-09-11 11:46:54 Calls for stronger governance and oversight in acquisitions following setbacks. |